The global blood preparation market size is expected to reach USD 63.57 billion by 2028 at a CAGR of 5.8%, according to the latest report by Reports and Data. Revenue growth of this market is mainly attributed to rising prevalence of blood-related disorders, increasing blood transfusion procedures, growing applications of blood components and derivatives in various surgical procedures, and increasing awareness about blood donation. Market growth is further accelerated by rising road accidents, increasing efforts to prevent thrombosis-associated complications, and development of anti-thrombotic and anti-coagulant drugs. Technological advancements in blood preparation methods and growing usage of blood derivatives such as platelet-rich plasma in procedures such as blood transfusion further bolster the global blood preparation market growth.
Blood preparation is the preparation of vital blood components including platelets, plasma, Red Blood Cells (RBCs), and White Blood Cells (WBCs). The method was first developed in 1960 to separate blood components from whole blood using a refrigerated centrifuge. Whole blood comprises crystalloids, colloids, and cells, and these are separated into different blood components such as platelet concentrates, Packed Red Blood Cell (PRBC) concentrate, frozen plasma, and cryoprecipitate. Blood components are prepared by the centrifugation of a single unit of whole blood. Blood preparation is carried out in clinical laboratories and blood centers. The method is extensively used in procedures such as blood transfusions.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4019
Market Dynamics:
Increasing development of on-demand, digitally enabled, and seamlessly connected clinician-patient interactions to manage patient base is expected to drive pharma and healthcare market in the coming years. After the COVID-19 outbreak there has been a number of foundational shifts in the healthcare system. Some of the examples include increasing consumer involvement in health care decision-making, the rapid adoption of virtual health & other digital innovations, increasing focus on utilization of interoperable data & data analytics, and increased public-private collaborations in therapeutics and vaccine development. The increased public-private collaborations for vaccine development has arisen due to high pressure of regional governments. Health care providers, and other stakeholders have invested heavily to quickly pivot, adapt, and innovate therapeutics.
Surging demands and transition to patient-centric care delivery across geographies will change pharma and healthcare market trends through 2028.
Competitive Outlook:
The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and Machine Learning to enhance efficiency of medical products. Top companies in the market are focusing on R&D activities to expand their product offerings and cater to unmet medical needs.
This report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, and recent developments in both historic and present contexts.
Top companies operating in the market and profiled in the report include:
Johnson & Johnson, GlaxoSmithKline PLC, Pfizer Inc., Celgene Corp, Baxter Healthcare Corp., AstraZeneca Co., Boehringer Ingelheim, Sanofi Aventis, Aralez Pharmaceuticals, Bristol-Myers Squibb Co., Leo Pharma Inc., Daiichi Sankyo, Shandong East Chemical Industry Co., Ionis Pharmaceuticals, and Bayer AG
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4019
The report segments the Blood Preparation market on the basis of product types, applications, end-use industries, and regions among others. The report offers insights into key factors influencing the revenue growth of the segment and provides information about lucrative investment opportunities to stakeholders, investors, and clients.
Blood Preparation Market Segmentation:
By Product Type (Revenue, USD Billion; 2018-2028)
Whole Blood
Red Cells
Platelets
Granulocytes
Plasma
Blood Components
Whole Blood Components
Leukocyte Reduced Red Blood Cells
Platelet Concentrates
Cryoprecipitate
Packed Red Cells
Frozen Plasma
Blood Derivatives
By Antithrombotic and Anticoagulant Type (Revenue, USD Billion; 2018-2028)
Platelet Aggregation Inhibitors
Glycoprotein Inhibitors
ADP Antagonists
COX Inhibitors
Others
Fibrinolytics
Tissue Plasminogen Activator (tPA)
Urokinase
Streptokinase
Anticoagulants
Heparins
Ultra-low Molecular Weight Heparin
Low Molecular Weight Heparin (LMWH)
Unfractionated Heparin
Vitamin K Antagonists
Direct Factor Xa Inhibitors
Direct Thrombin Inhibitors
By Application (Revenue, USD Billion; 2018-2028)
Angina Blood Vessel Complications
Pulmonary Embolism
Thrombocytosis
Renal Impairment
Others
Regional Analysis covers:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
To know more about the report @ https://www.reportsanddata.com/press-release/global-blood-preparation-market
Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized as per your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]